Alexza Pharma (ALXA) Tops Q4 EPS by 33c

Alexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.35), $0.33 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.45 billion, versus $1.3 million reported last year.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• ScanSource (SCSC) Tops Q4 EPS by 32c
• Twin Disc (TWIN) Tops Q4 EPS by 16c